Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Goetz

Showing results (181-190 of 269) with videos related to

Pageof 27
Sort By:
Advances in Neurology|January 1, 1982
Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pigW J Weiner, P Carvey, P A Nausieda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
The effect of changes in head posture on the patterns of muscle activity in cervical dystonia (CD)A S Buchman, C L Comella, S Leurgans, et al.
Life Sciences|May 12, 1986
The effect of thioridazine on haloperidol induced behavioral hypersensitivityH L Klawans, P M Carvey, D Nelson, et al.
Neurology|July 1, 1978
Lergotrile in the treatment of parkinsonismH L Klawans, C G Goetz, P Volkman, et al.
European Journal of Pharmacology|July 3, 1998
5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypesE J Pappert, C G Goetz, G T Stebbins, et al.
Brain and Cognition|April 8, 2000
Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's diseaseG T Stebbins, J D Gabrieli, K M Shannon, et al.
Clinical Neuropharmacology|December 1, 1987
Amantadine and motor fluctuations in chronic Parkinson's diseaseK M Shannon, C G Goetz, V S Carroll, et al.
Neurology|December 31, 1997
Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating ScaleD A Bennett, K M Shannon, L A Beckett, et al.
Annals of Neurology|September 1, 1996
Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's diseaseN Diederich, C Hilger, C G Goetz, et al.
Clinical Neuropharmacology|June 1, 1993
Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystoniaA S Buchman, C L Comella, G T Stebbins, et al.
Pageof 27

Showing results (181-190 of 269) with videos related to

Sort By:
Pageof 27
Advances in Neurology|January 1, 1982
Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pigW J Weiner, P Carvey, P A Nausieda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
The effect of changes in head posture on the patterns of muscle activity in cervical dystonia (CD)A S Buchman, C L Comella, S Leurgans, et al.
Life Sciences|May 12, 1986
The effect of thioridazine on haloperidol induced behavioral hypersensitivityH L Klawans, P M Carvey, D Nelson, et al.
Neurology|July 1, 1978
Lergotrile in the treatment of parkinsonismH L Klawans, C G Goetz, P Volkman, et al.
European Journal of Pharmacology|July 3, 1998
5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypesE J Pappert, C G Goetz, G T Stebbins, et al.
Brain and Cognition|April 8, 2000
Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's diseaseG T Stebbins, J D Gabrieli, K M Shannon, et al.
Clinical Neuropharmacology|December 1, 1987
Amantadine and motor fluctuations in chronic Parkinson's diseaseK M Shannon, C G Goetz, V S Carroll, et al.
Neurology|December 31, 1997
Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating ScaleD A Bennett, K M Shannon, L A Beckett, et al.
Annals of Neurology|September 1, 1996
Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's diseaseN Diederich, C Hilger, C G Goetz, et al.
Clinical Neuropharmacology|June 1, 1993
Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystoniaA S Buchman, C L Comella, G T Stebbins, et al.
Pageof 27